Other Events ·
Nasdaq determines to delist Charming Medical following SEC trading suspension for potential manipulation
MCTACharming Medical Ltd
The Nasdaq Stock Market notified Charming Medical Limited that it will be delisted from the exchange due to a determination by Listing Qualifications Staff under Rule IM-5101-4. This action follows an October 29, 2026 letter and stems from a U.S. Securities and Exchange Commission order issued on November 11, 2025, which suspended trading in the company's securities due to potential manipulation via social media recommendations designed to artificially inflate price and volume. Unless Charming Medical requests an appeal by November 5, 2026, trading will be suspended at the opening of business on November 9, 2026, after which Nasdaq will file a Form 25-NSE to remove the securities from listing. The company states that the delisting does not affect its ongoing operations or financial condition and may seek trading in the over-the-counter market. Charming Medical Limited is a Hong Kong-based provider of Traditional Chinese Medicine-inspired therapies and products.